From another perspective, it could be inferred that inhibition of CDK5RAP2, MAD1L1, and RGCC expression could suppress the proliferation, migration, and invasion of COAD cells, which might be an effective treatment strategy for COAD patients. Here, RGCC is linked to colon adenocarcinoma.